B6.129P2-Pik3cbtm2.1Bvan/Cnbc

Status

Available to order

EMMA IDEM:11630
International strain nameB6.129P2-Pik3cbtm2.1Bvan/Cnbc
Alternative namep110beta PI3K-D931A (B6)
Strain typeTargeted Mutant Strains : Knock-in
Allele/Transgene symbolPik3cbtm2.1Bvan
Gene/Transgene symbolPik3cb

Information from provider

ProviderBart Vanhaesebroeck
Provider affiliationUCL Cancer Institute, University College London
Additional ownerthe University of Edinburgh
Genetic informationKnock-in mice in which the endogenous Pik3cb/p110beta PI3K gene is mutated so that it now encodes a p110beta protein with the D931A mutation in the ATP binding site, converting it to a kinase-dead p110beta protein which is expressed at the same level as wild-type p110beta. These mice have been backcrossed onto the B6 background.
Phenotypic informationHomozygous:
Mice show prenatal partial lethality at different embryonic stages (see PMID 26132308 for details). Homozygous male mice that are born are infertile with smaller than normal testicles. They cannot produce offspring.

Heterozygous:
Mice show reduced phenotypes of homozygous.
Breeding historyBackcrossed onto C57BL/6J for more than 10 generations.
References
  • Novel Role for p110β PI 3-Kinase in Male Fertility through Regulation of Androgen Receptor Activity in Sertoli Cells.;Guillermet-Guibert Julie, Smith Lee B, Halet Guillaume, Whitehead Maria A, Pearce Wayne, Rebourcet Diane, León Kelly, Crépieux Pascale, Nock Gemma, Strömstedt Maria, Enerback Malin, Chelala Claude, Graupera Mariona, Carroll John, Cosulich Sabina, Saunders Philippa T K, Huhtaniemi Ilpo, Vanhaesebroeck Bart, ;2015;PLoS genetics;11;e1005304; 26132308
Homozygous fertilefemales only
Homozygous viablenot known
Homozygous matings requiredno
Immunocompromisednot known

Information from EMMA

Archiving centreCNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain
Animals used for archivingheterozygous C57BL/6JOlaHsd

Disease and phenotype information

IMPC phenotypes (gene matching)
  • increased hemoglobin content / IMPC
  • hypoplasia / IMPC
  • increased mean corpuscular hemoglobin / IMPC
  • decreased circulating creatinine level / IMPC
  • abnormal coat/hair pigmentation / IMPC
MGI phenotypes (gene matching)
  • decreased body weight / MGI
  • weight loss / MGI
  • decreased embryo size / MGI
  • postnatal growth retardation / MGI
  • decreased circulating triglyceride level / MGI
  • increased insulin secretion / MGI
  • abnormal gluconeogenesis / MGI
  • decreased lumbar vertebrae number / MGI
  • decreased circulating cholesterol level / MGI
  • insulin resistance / MGI
  • decreased heart rate / MGI
  • decreased glycogen level / MGI
  • abnormal platelet physiology / MGI
  • pancreatic islet hyperplasia / MGI
  • decreased circulating creatinine level / MGI
  • increased circulating glucose level / MGI
  • increased mean corpuscular hemoglobin / MGI
  • increased hemoglobin content / MGI
  • increased lung weight / MGI
  • pulmonary fibrosis / MGI
  • decreased physiological sensitivity to xenobiotic / MGI
  • decreased platelet aggregation / MGI
  • decreased birth body size / MGI
  • decreased sensitivity to xenobiotic induced morbidity/mortality / MGI
  • embryonic lethality between somite formation and embryo turning, complete penetrance / MGI
  • preweaning lethality, complete penetrance / MGI
  • embryonic lethality, incomplete penetrance / MGI
  • embryonic lethality before implantation, incomplete penetrance / MGI
  • embryonic lethality during organogenesis, incomplete penetrance / MGI
  • lethality throughout fetal growth and development, incomplete penetrance / MGI
  • decreased fibroblast proliferation / MGI

Literature references

  • Novel Role for p110β PI 3-Kinase in Male Fertility through Regulation of Androgen Receptor Activity in Sertoli Cells.;Guillermet-Guibert Julie, Smith Lee B, Halet Guillaume, Whitehead Maria A, Pearce Wayne, Rebourcet Diane, León Kelly, Crépieux Pascale, Nock Gemma, Strömstedt Maria, Enerback Malin, Chelala Claude, Graupera Mariona, Carroll John, Cosulich Sabina, Saunders Philippa T K, Huhtaniemi Ilpo, Vanhaesebroeck Bart, ;2015;PLoS genetics;11;e1005304; 26132308

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).